Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
1.
Rev. colomb. biotecnol ; 13(2): 221-228, dic 1, 2011.
Article in Spanish | LILACS | ID: lil-645182

ABSTRACT

La propagación de material de ñame de buena calidad es esencial para incrementar la producción sostenible de este cultivo. El presente trabajo tuvo como propósito optimizar el medio de cultivo de micropropagación de Dioscorea alata L. clon Caraqueño a través de los siguientes objetivos: determinar el efecto de diferentes antioxidantes (carbón activado 0,5 g/L-1 ; carbón activado 1,0 g/L-1; cisteína 10 mg/L-1, 20 mg/L-1 y 30 mg/L-1) y concentraciones de sales de Murashige y Skoog (MS) (25, 50, 75 y 100 %) en el medio de cultivo durante el establecimiento y la multiplicación de las plantas in vitro, y evaluar la utilización de distintas combinaciones de ácido naftalenacético (0,01; 0,1 mg/L-1) y bencilaminopurina (0,01; 0,1 mg/L-1) en el mejor medio de cultivo de multiplicación obtenido en el experimento anterior. A los 35 días se seleccionaron 40 plantas in vitro, a las cuales se les determinaron las siguientes variables: longitud en cm del vástago; número de nudos de novo por explantes; número de hojas por explante y porcentaje de fenolización. Se evaluó además, en el experimento con los reguladores de crecimiento, el número de raíces y longitud de la raíz de mayor tamaño. Se aplicó un diseño experimental completamente aleatorio con análisis de varianza bifactorial y clasificación simple. Se realizó la prueba de comparación de medias de Tukey para un nivel de significación del 5%. Los resultados obtenidos mostraron que las sales MS al 75% de su concentración, el carbón activado (0,5 g/L-1) o la cisteína (10 mg/L-1), en combinación con los reguladores de crecimiento ANA/BAP (0,01/0,01 mg/L-1) en el medio de cultivo MS, incrementaron los indicadores de desarrollo de las plantas in vitro tales como número de nudos de novo (3,5), longitud del vástago (4,1 cm), número de hojas (3,8), número de raíces (5,7) y longitud de las raíces (6 cm).


The material propagation of good quality yam is essential to increase the sustainable production of this cultivation. In the present work the optimization of culture medium of Dioscorea alata L. clone Caraqueño micropropagation was carried out through the following objectives: to determine the effect of different anti-oxydants (activated charcoal 0,5 g.L-1; activated charcoal 1,0 g.L-1; cysteine 10 mg.L-1, 20 mg.L-1 and 30 mg.L-1) and Murashige and Skoog salts concentrations (25, 50, 75 and 100%) in the culture medium during the in vitro plants establishment and the multiplication, and to evaluate the use of different combinations of naftalenacetic acid (0,01; 0,1 mg.L-1) and benzylaminopurine (0,01; 0,1 mg.L-1) in the best multiplication medium obtained in the above experiment. At 35 days, 40 in vitro plants were selected. The following variables were determined in these plants: shoot length, cm; leaf and bud explant number; and oxydation phenolic percentage. In the experiment of plant growth regulators was also evaluated, the roots number and greater size root length. A totally randomized experimental design with one and two factor variance analysis and the Tukey test for means comparison at 5% significance level were applied. The obtained results showed that the salts MS at 75% concentration, the activated charcoal (0,5 g. L-1) or the cysteine (10 mg. L-1), in combination with the growth regulators ANA/BAP (0,01/0,01 mg.L-1) in the MS culture medium, increase the development of the in vitro plants, number of novo buds (3,5), shoot length (4,1 cm), number of leaves (3,8), number of roots (5,7) and greater size root length (6 cm).


Subject(s)
Dioscorea/immunology , Dioscorea/microbiology , Dioscorea/chemistry , Cysteine/economics , Cysteine/adverse effects , Cysteine/pharmacology
2.
Journal of Korean Medical Science ; : 585-587, 2006.
Article in English | WPRIM | ID: wpr-65019

ABSTRACT

Bucillamine is a disease modifying anti-rheumatic drug, structurally similar to D-penicillamine. Although D-penicillamine-induced pemphigus has been not infrequently demonstrated, pemphigus associated with bucillamine was rarely reported. We describe a patient complicating pemphigus vulgaris after bucillamine treatment in rheumatoid arthritis (RA) and polymyositis (PM) overlap syndrome. PM and RA overlap syndrome was diagnosed three years ago and bucillamine was administrated for 20 months. Skin lesions including erythematous flaccid blisters on her chest, axillae, and back were occurred and were compatible with pemphigus vulgaris by typical pathology. Withdrawal from bucillamine and prednisolone treatment made rapid improvement of pemphigus lesions.


Subject(s)
Middle Aged , Humans , Female , Syndrome , Skin/pathology , Polymyositis/complications , Pemphigus/chemically induced , Cysteine/adverse effects , Biopsy , Arthritis, Rheumatoid/complications , Arthritis , Antioxidants/adverse effects
3.
The Korean Journal of Internal Medicine ; : 36-39, 2001.
Article in English | WPRIM | ID: wpr-99477

ABSTRACT

We describe a patient with rheumatoid arthritis(RA) who developed bronchiolitis obliterans organizing pneumonia(BOOP) during the treatment of bucillamine. A 51 year-old man was admitted to the hospital for an abnormal shadow on his chest radiogragh. He had been diagnosed as having RA 3 years previously and had been receiving 200 mg of bucillamine for 21 months. Two months prior to admission, he presented with a cough and his chest X-ray showed opacities in both lower lungs. He was treated with antibiotics for 2 months after the development of cough and lesions on the chest X-ray, but the symptoms and lung lesions became more aggravated. On admission, an HRCT revealed airspace consolidations in the subpleural space of both basal lungs and a CT-guided fine needle aspiration biopsy showed Masson's body filling air space, interstitial infiltration of acute and chronic inflammatory cells and type II cell hyperplasia, consistent with BOOP. Bucillamine was stopped and 50 mg of prednisolone was administered. His symptoms and infiltrations on the chest X-ray resolved. We suggest that bucillamine should be considered as a drug possibly associated with BOOP.


Subject(s)
Humans , Male , Anti-Inflammatory Agents, Non-Steroidal/therapeutic use , Anti-Inflammatory Agents, Non-Steroidal/adverse effects , Arthritis, Rheumatoid/drug therapy , Biopsy, Needle , Cryptogenic Organizing Pneumonia/diagnosis , Cryptogenic Organizing Pneumonia/chemically induced , Cysteine/therapeutic use , Cysteine/analogs & derivatives , Cysteine/adverse effects , Follow-Up Studies , Middle Aged , Radiography, Thoracic , Risk Assessment , Tomography, X-Ray Computed
SELECTION OF CITATIONS
SEARCH DETAIL